VRTX · News · 20260817N

Acquisition / Partnership / Divestiture

VERTEX PHARMACEUTICALS INC / MA · 2026-08-17 · Importance 65 · Surprise 60

Vertex proposed acquiring Crinetics Pharmaceuticals in an all-cash transaction. Crinetics shareholders would receive $85.00 for each share owned. The transaction is being reviewed by Kahn Swick & Foti, which is investigating the adequacy of the consideration and sale process.

Key facts

• AIGH Capital Management LLC purchased 2,486,038 shares of Vertex Pharmaceuticals valued at approximately $26.7 million in the second quarter. source
• Flputnam Investment Management Co. purchased 40,116 shares of Vertex Pharmaceuticals valued at approximately $19.93 million during the second quarter. source
• Global Retirement Partners LLC purchased 3,925 shares of Vertex Pharmaceuticals during the second quarter valued at approximately $1,950,000. source
• Simplicity Wealth LLC acquired 2,792 shares of Vertex Pharmaceuticals valued at approximately $1.39 million during the second quarter. source
• Plato Investment Management Ltd acquired 6,083 shares of Vertex Pharmaceuticals valued at approximately $3 million during the second quarter. source
• Trivium Point Advisory LLC purchased 2,199 shares of Vertex Pharmaceuticals valued at approximately $1.092 million during the second quarter. source
• Institutions collectively own 90.96% of Vertex Pharmaceuticals' stock. source
• Vertex Pharmaceuticals' stock traded at $515.55 on Monday, rising 1.94% and breaking a three-day losing streak. source